ZURICH/BERLIN, Feb 26 (Reuters) - Here are some of the
main factors that may affect Swiss stocks on Monday:
ROCHE ROG.S
Xolair, an asthma drug sold by Roche and Novartis NOVN.S ,
significantly reduced allergic reactions in people with multiple
severe food allergies in a late-stage trial, researchers
reported on Sunday at a medical meeting.
TX GROUP TXGN.S
Wants to sell its three printing plants in Switzerland as
well as office buildings for hundreds of millions of Swiss
francs, newspaper NZZ am Sonntag reported on Sunday.
TEMENOS TEMN.S
Announces appointment of independent third parties.
ANALYSTS' VIEWS
ROCHE HOLDING: JEFFERIES CUTS TARGET PRICE TO CHF 250 FROM
CHF 275
ECONOMY
SNB data on Swiss sight deposits due at 0900 GMT.
(Reporting by Zurich newsroom and Berlin Hub)
((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES
Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH
All equity news E
SPEED GUIDES: EQUITY EQUITY/NEWS1 EUR/EQUITY SWITZERLAND REUTERS ))